相关实验视频

Updated: May 1, 2026

Measuring Connectivity in the Primary Visual Pathway in Human Albinism Using Diffusion Tensor Imaging and Tractography

Measuring Connectivity in the Primary Visual Pathway in Human Albinism Using Diffusion Tensor Imaging and Tractography

Published on: August 11, 2016

白物质结构连接和阿尔茨海默病:一项门德尔随机化研究

Siyu Liu¹, Daoying Geng^1,2,3

¹Radiology Department, Huashan Hospital, Affiliated with Fudan University, Shanghai, China.

Brain and behavior

|February 10, 2025

概括

这项研究使用了门德尔的随机化来研究白质连接与阿尔茨海默病 (AD) 之间的因果关系. 某些白质途径与AD风险有显著的关联,为未来的治疗提供了潜在的见解.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
神经学神经学

背景情况:

观察性研究表明,阿尔茨海默病 (AD) 和白质结构连接性之间存在联系.
白质结构连接和AD之间的因果关系仍然不清楚.

研究的目的:

为了研究白质结构连接对阿尔茨海默病 (AD) 的影响,使用两样多变量门德尔随机化 (MR) 方法.
为了确定特定的白质连接是否因果关系地影响AD风险.

主要方法:

利用全基因组关联研究 (GWAS) 的数据来检测白质结构连接性 (Wainberg等). 和AD (贝伦格雷斯等人. ) 的情况.
采用了各种MR方法,包括逆方差加权,MR-Egger,简单模式,加权中位数和加权模式.
通过异质性,水平变性和留出一个的分析来评估强度;进行了反向MR分析.

主要成果:

在206个白质结构连接中,确定了10个与AD的遗传敏感性显著相关的结构连接.
右半球边缘网络到 thalamus 和 salience-ventral 注意网络到 accumbens 连接与AD概率正相关.
其他八个连接显示与AD的负相关性;没有发现反向因果关系.

结论:

该MR研究表明,特定的白质结构连接模式与阿尔茨海默病之间存在显著的关联.
这些发现可能会为未来的AD诊断和治疗策略提供信息.
突出了特定大脑网络连接在阿尔茨海默病变的潜在作用.

关键词:

阿尔茨海默氏症全基因组关联研究门德尔随机化右半球边缘网络到丘脑白质结构连接白质结构连接白质结构连接

更多相关视频

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...